Neuraxis Inc (NRXS) Stock Price, Quote & News

Company Profile

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a...

Industry: Biotechnology

Sector: Healthcare

Phone: 812 689 0791

Website: neuraxis.com

Address:

11611 North Meridian St, Suite 330, Carmel, United States

Finnish_boy Jun. 9 at 4:11 PM

$NRXS Added $6.5, next buy $5.75-$6.25

0 · Reply

Finnish_boy Jun. 9 at 1:55 PM

$NRXS If stock drops to 5s, it wont be there long time bc that triggers multiple substack articles and twitter posts.

1 · Reply

Finnish_boy Jun. 9 at 1:21 PM

$NRXS Does someone know when they announce the coverage? According history H2 June- July is very active time to announce new policy changes. Coverage can kick in right away or e.g start of August/September.

1 · Reply

CBAZZ03 Jun. 6 at 3:33 PM

$NRXS Hey everyone, just realized that there is a community here for NeurAxis. Done A TON of research on this company, can confidently say i’m a VERY bullish on this company, absolutely 0 reason to NOT buy this stock, going to easily 2x by EOY!

2 · Reply

Finnish_boy Jun. 1 at 7:02 PM

$NRXS Forming potential bottom low 7s.

0 · Reply

Finnish_boy Jun. 1 at 3:44 PM

$NRXS We need Cunha

1 · Reply

SuperGreenToday May. 30 at 12:55 AM

$NRXS

0 · Reply

Finnish_boy May. 27 at 2:01 PM

$NRXS If someone wonders why stock is up.

0 · Reply

Finnish_boy May. 27 at 7:42 AM

$NRXS Sold all low 8s and 7.5s. I realized stock performance is all about Cunha's twitter posts and substrack. He became quiet so i sold. I bought first batch back at $7.1 .. no catalyst before potential coverage win late June/July. 1Y PT $15. By the end of year $10. Max pain is $6.4. Triggers multiple twitter posts and new deep dive. At $5.9 Microcapclub step in with new Ceo interview.

1 · Reply

cleverrox May. 22 at 2:57 PM

$NRXS https://microcapopportunities.substack.com/p/neuraxis-va-ramp

0 · Reply

NeurAxis Transcript: Lytham Partners Spring 2026 Investor Conference

May 27, 2026, 7:00 AM EDT - 19 days ago

NeurAxis Slides: Investor presentation

May 12, 2026, 9:00 AM EDT - 4 weeks ago

NeurAxis Earnings Call Transcript: Q1 2026

May 12, 2026, 9:00 AM EDT - 4 weeks ago

NeurAxis Quarterly report: Q1 2026

May 12, 2026, 9:00 AM EDT - 4 weeks ago

NeurAxis Earnings release: Q1 2026

May 12, 2026, 7:05 AM EDT - 4 weeks ago

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

May 5, 2026, 7:00 AM EDT - 5 weeks ago

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

Apr 28, 2026, 8:00 AM EDT - 6 weeks ago

NeurAxis Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 6 weeks ago

NeurAxis Proxy statement: Proxy filing

Apr 22, 2026, 7:00 AM EDT - 7 weeks ago

NeurAxis Expands Payer Coverage with Four New Medical Policies

Apr 10, 2026, 7:00 AM EDT - 2 months ago

NeurAxis, Inc. Announces Preferred Stock Dividend

2026-03-20T12:56:08.000Z - 3 months ago

Neuraxis price target raised to $13 from $8 at Craig-Hallum

Mar 19, 2026, 9:00 AM EDT - 3 months ago

NeurAxis Earnings Call Transcript: Q4 2025

Mar 19, 2026, 9:00 AM EDT - 3 months ago

NeurAxis Earnings release: Q4 2025

Mar 19, 2026, 9:00 AM EDT - 3 months ago

NeurAxis Annual report: Q4 2025

2026-03-19T11:25:31.000Z - 3 months ago

Neuraxis reports Q4 revenue $968K vs. $761K last year

Mar 19, 2026, 7:05 AM EDT - 3 months ago

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

Jan 30, 2026, 7:00 AM EST - 4 months ago

NeurAxis Slides: Corporate presentation

Jan 15, 2026, 9:30 AM EST - 5 months ago

NeurAxis Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit

2026-01-08T13:38:18.000Z - 5 months ago

Neuraxis announces Category I CPT code for PENFS now in effect

2026-01-05T16:05:09.000Z - 5 months ago

Neuraxis management to meet virtually with Craig-Hallum

2025-12-22T15:25:50.000Z - 6 months ago

Neuraxis management to meet virtually with Craig-Hallum

2025-12-22T14:30:21.000Z - 6 months ago

Neuraxis price target raised to $8 from $7 at Craig-Hallum

2025-12-19T13:15:39.000Z - 6 months ago

Neuraxis achieves medical coverage policy milestone for PENFS

2025-12-01T12:20:49.000Z - 7 months ago

Neuraxis secures VA Federal Supply Schedule contract

2025-11-12T13:31:25.000Z - 7 months ago

Neuraxis announces new medical policy coverage in Michigan

Nov 11, 2025, 9:00 AM EST - 7 months ago

NeurAxis Earnings Call Transcript: Q3 2025

Nov 11, 2025, 9:00 AM EST - 7 months ago

NeurAxis Earnings release: Q3 2025

Nov 11, 2025, 9:00 AM EST - 7 months ago

NeurAxis Quarterly report: Q3 2025

2025-11-11T12:06:10.000Z - 7 months ago

Neuraxis reports Q3 revenue $811k vs $667k last year

Nov 11, 2025, 7:00 AM EST - 7 months ago

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

2025-10-24T12:11:28.000Z - 8 months ago

Neuraxis received FDA 510k clearance for PENFS technology

Sep 30, 2025, 11:00 AM EDT - 9 months ago

NeurAxis Transcript: Lytham Partners Fall 2025 Investor Conference

Aug 12, 2025, 9:00 AM EDT - 10 months ago

NeurAxis Earnings Call Transcript: Q2 2025

Aug 12, 2025, 9:00 AM EDT - 10 months ago

NeurAxis Earnings release: Q2 2025

Aug 12, 2025, 9:00 AM EDT - 10 months ago

NeurAxis Quarterly report: Q2 2025

Aug 12, 2025, 9:00 AM EDT - 10 months ago

NeurAxis Slides: Q2 2025

2025-08-12T11:06:07.000Z - 10 months ago

Neuraxis reports Q2 EPS (22c) vs. (42c) last year

2025-06-19T20:45:06.000Z - 1 year ago

Neuraxis management to meet with Craig-Hallum

2025-06-17T12:10:40.000Z - 1 year ago

Neuraxis announces new medical policy with two health insurers

Jun 17, 2025, 8:00 AM EDT - 1 year ago

NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives

2025-06-16T13:15:09.000Z - 1 year ago

Craig-Hallum bullish on Neuraxis, initiates with a Buy

2025-06-16T11:30:07.000Z - 1 year ago

Neuraxis initiated with a Buy at Craig-Hallum

2025-06-10T12:30:42.000Z - 1 year ago

Neuraxis secures key academic society guidelines recommendation for FAP

May 29, 2025, 9:30 AM EDT - 1 year ago

NeurAxis Transcript: Lytham Partners Spring 2025 Investor Conference

2025-05-23T15:10:13.000Z - 1 year ago

Biotech Alert: Searches spiking for these stocks today

AKRO APVO CVM ETNB NLSP RLMD TIL

May 22, 2025, 1:03 PM EDT - 1 year ago

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering

2025-05-22T14:41:04.000Z - 1 year ago

Biotech Alert: Searches spiking for these stocks today

ARMP NLSP NVAX PRME TIL TNGX

2025-05-21T11:15:19.000Z - 1 year ago

Neuraxis prices 1.54M shares at $3.25 in registered direct offering

May 21, 2025, 7:00 AM EDT - 1 year ago

NeurAxis Announces $5.0 Million Registered Direct Offering

May 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings Call Transcript: Q1 2025

May 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings release: Q1 2025

May 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Quarterly report: Q1 2025

May 12, 2025, 8:15 AM EDT - 1 year ago

NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues

May 5, 2025, 9:00 AM EDT - 1 year ago

NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025

Apr 23, 2025, 5:00 PM EDT - 1 year ago

NeurAxis Transcript: Planet MicroCap Showcase: VEGAS 2025

Apr 14, 2025, 8:00 AM EDT - 1 year ago

NeurAxis Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

NeurAxis Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

NeurAxis Proxy statement: Proxy Filing

Mar 20, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings Call Transcript: Q4 2024

Mar 20, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings release: Q4 2024

Mar 20, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Annual report: Q4 2024

Mar 20, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Slides: Q4 2024

Mar 20, 2025, 8:15 AM EDT - 1 year ago

NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues

Mar 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025

Feb 5, 2025, 7:00 AM EST - 1 year ago

NeurAxis Registration statement: Registration Filing

Jan 21, 2025, 1:45 PM EST - 1 year ago

UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States

Jan 21, 2025, 9:00 AM EST - 1 year ago

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

Jan 13, 2025, 2:30 PM EST - 1 year ago

NeurAxis Transcript: Lytham Partners 2025 Investor Healthcare Summit

Jan 13, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. Issues Letter to Shareholders

Jan 6, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Dec 13, 2024, 7:00 AM EST - 1 year ago

NeurAxis Registration statement: Registration Filing

Nov 12, 2024, 9:00 AM EST - 1 year ago

NeurAxis Earnings Call Transcript: Q3 2024

Nov 12, 2024, 9:00 AM EST - 1 year ago

NeurAxis Quarterly report: Q3 2024

Nov 12, 2024, 9:00 AM EST - 1 year ago

NeurAxis Earnings release: Q3 2024

Nov 12, 2024, 9:00 AM EST - 1 year ago

NeurAxis Slides: Q3 2024

Nov 12, 2024, 8:10 AM EST - 1 year ago

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

Oct 22, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation

Oct 1, 2024, 12:30 PM EDT - 1 year ago

NeurAxis Transcript: Lytham Partners Fall 2024 Investor Conference

Sep 19, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

Aug 27, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024

Aug 13, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024

Aug 9, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Earnings Call Transcript: Q2 2024

Aug 9, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Quarterly report: Q2 2024

Aug 9, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Earnings release: Q2 2024

Aug 9, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Reports Second Quarter 2024 Financial Results

Jul 1, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Proxy statement: Proxy Filing

Jul 1, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Proxy statement: Proxy Filing

Jun 21, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Proxy statement: Proxy Filing

Jun 7, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure

May 22, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Earnings Call Transcript: Q1 2024

May 22, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Quarterly report: Q1 2024

May 22, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Earnings release: Q1 2024

May 22, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Reports First Quarter 2024 Financial Results

May 21, 2024, 9:00 AM EDT - 2 years ago

NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024

Apr 23, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces New Medical Policy Coverage in North Dakota

Apr 9, 2024, 4:05 PM EDT - 2 years ago

NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Apr 9, 2024, 7:00 AM EDT - 2 years ago

NeurAxis Annual report: Q4 2023

Apr 9, 2024, 7:00 AM EDT - 2 years ago

NeurAxis Earnings release: Q4 2023

Apr 1, 2024, 4:15 PM EDT - 2 years ago

NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024

Mar 27, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry

Mar 11, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces Highmark BCBS Policy Coverage

Mar 4, 2024, 9:00 AM EST - 2 years ago

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

Feb 27, 2024, 11:00 AM EST - 2 years ago

NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Jan 31, 2024, 9:00 AM EST - 2 years ago

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

Dec 20, 2023, 9:00 AM EST - 2 years ago

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

Nov 20, 2023, 5:30 PM EST - 2 years ago

NeurAxis Reports Third Quarter 2023 Financial Results

Nov 20, 2023, 8:00 AM EST - 2 years ago

NeurAxis Quarterly report: Q3 2023

Nov 20, 2023, 8:00 AM EST - 2 years ago

NeurAxis Earnings release: Q3 2023

Nov 15, 2023, 9:00 AM EST - 2 years ago

NeurAxis Announces CareFirst BCBS Policy Coverage

Nov 14, 2023, 9:00 AM EST - 2 years ago

NeurAxis Secures $3 Million Financing

Nov 8, 2023, 9:00 AM EST - 2 years ago

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

Sep 21, 2023, 8:00 AM EDT - 2 years ago

NeurAxis Reports Second Quarter 2023 Financial Results

Sep 21, 2023, 8:00 AM EDT - 2 years ago

NeurAxis Quarterly report: Q2 2023

Sep 21, 2023, 8:00 AM EDT - 2 years ago

NeurAxis Earnings release: Q2 2023

Sep 13, 2023, 9:00 AM EDT - 2 years ago

NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase

Sep 12, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS

Aug 29, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Highlights Pediatric Post-Concussion Clinical Study

Aug 24, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Highlights Strength of its Board of Directors

Aug 22, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome

Aug 17, 2023, 9:02 AM EDT - 3 years ago

NeurAxis Announces Over $8 Million in IB-Stim™ Revenue

Aug 15, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023

Aug 11, 2023, 9:30 AM EDT - 3 years ago

Goldman Small Cap Research Publishes New Research Report on NeurAxis, Inc.

Aug 9, 2023, 10:00 AM EDT - 3 years ago

NeurAxis Announces Pricing of Initial Public Offering

Finnish_boy Jun. 9 at 4:11 PM

$NRXS Added $6.5, next buy $5.75-$6.25

0 · Reply

Finnish_boy Jun. 9 at 1:55 PM

$NRXS If stock drops to 5s, it wont be there long time bc that triggers multiple substack articles and twitter posts.

1 · Reply

Finnish_boy Jun. 9 at 1:21 PM

1 · Reply

CBAZZ03 Jun. 6 at 3:33 PM

2 · Reply

Finnish_boy Jun. 1 at 7:02 PM

$NRXS Forming potential bottom low 7s.

0 · Reply

Finnish_boy Jun. 1 at 3:44 PM

$NRXS We need Cunha

1 · Reply

SuperGreenToday May. 30 at 12:55 AM

$NRXS

0 · Reply

Finnish_boy May. 27 at 2:01 PM

$NRXS If someone wonders why stock is up.

0 · Reply

Finnish_boy May. 27 at 7:42 AM

1 · Reply

cleverrox May. 22 at 2:57 PM

$NRXS https://microcapopportunities.substack.com/p/neuraxis-va-ramp

0 · Reply

stocktrader1549 May. 19 at 11:28 PM

$NRXS junk

0 · Reply

Finnish_boy May. 19 at 9:13 AM

$NRXS If no cunha posts, then i expect trading between 7 and 8 until the new coverage news that are out in late June.

0 · Reply

stocktrader1549 May. 18 at 1:59 PM

$NRXS junk

1 · Reply

Finnish_boy May. 17 at 11:01 AM

Multibaggers that i shouldnt have missed: RKLB and LQDA. Next multibaggers that i will not miss: $HROW $PYPD $NRXS I like also IREN, CIFR, HITI, and TMDX.

1 · Reply

Finnish_boy May. 15 at 11:49 AM

$NRXS https://mvcinvesting.substack.com/p/neuraxis-nrxs-q1-2026-earnings-review

0 · Reply

Finnish_boy May. 14 at 6:04 PM

$NRXS $MVC

0 · Reply

Finnish_boy May. 14 at 5:45 PM

$NRXS Bought more for trade. I wait now cunha X post about new article. PT $9 this week.

0 · Reply

Finnish_boy May. 14 at 5:31 PM

$NRXS If you wonder why stock jumped little bit. this stock is all about cunha. cunha is one of the best investors i know.

1 · Reply

Finnish_boy May. 13 at 3:08 PM

$NRXS We need Cunha😭

0 · Reply

Finnish_boy May. 12 at 2:44 PM

$NRXS 15M revenue is breakeven. If no Cunha or Microcaoclub, stock would be well under $7.

2 · Reply

Finnish_boy May. 12 at 2:39 PM

$NRXS Revenue ramp up maybe slower than i think. But i think stock hits $10 this year for sure. 1y pt $15

0 · Reply

Finnish_boy May. 12 at 2:35 PM

$NRXS Did they tell anything more info on call? Any revenue estimates for next quarters or when major coverage win happen?

0 · Reply

Market Cap	82.97M
Revenue (ttm)	3.57M
Net Income (ttm)	-7.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-218.49%
Debt to Equity Ratio	0.00

Volume	81,116
Avg Vol	162,954
Day's Range	N/A - N/A
Shares Out	12.38M
Stochastic %K	33%
Beta	1.42
Analysts	Strong Sell
Price Target	$13.00